AQST
USDAquestive Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$6.410
Максимум
$6.410
Минимум
$5.790
Объем
3.85M
Фундаментальные показатели компании
Рыночная капитализация
736.9M
Отрасль
Drug Manufacturers - Specialty & Generic
Страна
United States
Статистические данные торговли
Средний объем
3.10M
Биржа
NGM
Валюта
USD
52-недельный диапазон
Связанные новости
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D.,
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
WARREN, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
WARREN, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.